IMEGX
Price
$21.92
Change
+$0.09 (+0.41%)
Updated
Jun 26 closing price
Net Assets
686.51M
RNWHX
Price
$87.45
Change
+$0.90 (+1.04%)
Updated
Jun 26 closing price
Net Assets
68.99B
Interact to see
Advertisement

IMEGX vs RNWHX

Header iconIMEGX vs RNWHX Comparison
Open Charts IMEGX vs RNWHXBanner chart's image
Macquarie Systematic Em Mkts Eq R6
Price$21.92
Change+$0.09 (+0.41%)
VolumeN/A
Net Assets686.51M
American Funds New World R5E
Price$87.45
Change+$0.90 (+1.04%)
VolumeN/A
Net Assets68.99B
IMEGX vs RNWHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IMEGX vs. RNWHX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMEGX is a Buy and RNWHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 69B vs. IMEGX (687M). IMEGX pays higher dividends than RNWHX: IMEGX (3.35) vs RNWHX (1.04). IMEGX was incepted earlier than RNWHX: IMEGX (11 years) vs RNWHX (10 years). IMEGX (1.11) is less costly to investors than RNWHX (0.72). RNWHX is a more actively managed with annual turnover of: 37.00 vs. IMEGX (30.00). RNWHX annual gain was more profitable for investors over the last year : 11.19 vs. IMEGX (10.19). RNWHX return over 5 years is better than : 35.11 vs. IMEGX (18.69).
IMEGXRNWHXIMEGX / RNWHX
Total Expense Ratio0.650.7290%
Annual Report Gross Expense Ratio1.110.72154%
Fund Existence11 years10 years-
Gain YTD13.10615.03687%
Front LoadN/AN/A-
Min. Initial InvestmentN/A250-
Min. Initial Investment IRAN/AN/A-
Net Assets687M69B1%
Annual Yield % from dividends3.351.04322%
Returns for 1 year10.1911.1991%
Returns for 3 years14.1735.3540%
Returns for 5 years18.6935.1153%
Returns for 10 years46.40N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADIL0.470.24
+104.88%
Adial Pharmaceuticals
SKYE4.250.56
+15.18%
Skye Bioscience
OVV38.730.73
+1.92%
Ovintiv
MPW4.500.05
+1.12%
Medical Properties Trust
PRA22.880.03
+0.13%
ProAssurance Corp